S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Takeda Pharmaceutical Earnings Date, Estimates & History

-0.46 (-2.57 %)
(As of 01/15/2021 12:00 AM ET)
Today's Range
Now: $17.44
50-Day Range
MA: $18.37
52-Week Range
Now: $17.44
Volume4.13 million shs
Average Volume3.26 million shs
Market Capitalization$54.98 billion
P/E Ratio38.76
Dividend Yield4.13%


Takeda Pharmaceutical (NYSE:TAK) Earnings Information

Takeda Pharmaceutical last issued its quarterly earnings data on October 29th, 2020. The reported $0.47 earnings per share for the quarter. The business earned $7.43 billion during the quarter. Takeda Pharmaceutical has generated $1.78 earnings per share over the last year and currently has a price-to-earnings ratio of 38.8. Takeda Pharmaceutical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 2nd, 2021 based off prior year's report dates.

Takeda Pharmaceutical Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Takeda Pharmaceutical (NYSE:TAK) Earnings Estimates

Current Year EPS Consensus Estimate: $2.09 EPS

Takeda Pharmaceutical (NYSE TAK) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
10/29/2020Q2 2021$0.47$0.93$7.43 billionN/A
7/31/2020Q1 2021$0.57$0.89$7.46 billionN/A
5/13/2020Q4 2020$0.13$0.25$7.09 billionN/A
2/4/2020Q3 2020$0.53$1.03$7.90 billionListen
10/31/2019Q2 2020$0.59$1.02$7.56 billionTranscript
7/31/2019Q1 2020$0.56$1.18$7.73 billionN/A
5/14/2019Q4 2019$0.13$0.13$3.51 billionN/A
2/1/2019Q3 2019$0.75$1.29$4.43 billionN/A
10/31/2018Q2 2019$0.61$0.94$3.86 billionN/A
7/31/2018Q1 2019$0.69$0.92$4.12 billionN/A
5/14/2018Q4 2018($0.32)($0.32)$3.70 billionN/A
2/1/2018Q3 2018$0.39$0.39$4.33 billionN/A
11/1/2017Q2 2018$0.46$0.76$3.91 billionN/A
7/28/2017Q1 2018$0.47$0.10$4.04 billionN/A
5/10/2017Q4 2017($0.29)($0.29)$3.66 billionN/A
2/1/2017Q3 2017$0.24$0.24$4.27 billionN/A
10/28/2016Q2 2017$0.16$0.16$4.07 billionN/A
7/29/2016Q1 2017$0.59$0.59$4.02 billionN/A
5/10/2016Q4 2016$0.07$0.33$3.59 billionN/A
2/3/2016Q3 2016$0.31$0.31$4.06 billionN/A
10/30/2015Q2 2016$0.15$0.15$3.75 billionN/A
7/30/2015Q1 2016$0.13$0.13$3.66 billionN/A
5/15/2015Q4 2015$0.05$1.30$3.67 billionN/A
2/5/2015Q3 2015$0.10$0.10$4.15 billionN/A
10/30/2014Q2 2015$0.16$0.16$4.08 billionN/A
8/1/2014Q1 2015$0.21$0.21$4.02 billionN/A
5/8/2014Q4 2014($0.03)($0.03)$3.98 billionN/A
2/5/2014Q3 2014$0.29$0.29$4.53 billionN/A
10/31/2013Q2 2014$0.14$0.05$4.22 billionN/A
7/31/2013Q1 2014$0.20$0.21$4.17 billionN/A
5/9/2013Q4 2013$0.54$0.79$3.72 billionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.